Bio-Techne
TECH
#1525
Rank
NZ$19.40 B
Marketcap
$122.11
Share price
0.32%
Change (1 day)
15.39%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$1.02 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are NZ$1.02 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30NZ$1.10 B16.15%
2022-06-30NZ$0.95 B-3.61%
2021-06-30NZ$0.98 B-1.6%
2020-06-30NZ$1.00 B-5.95%
2019-06-30NZ$1.06 B40.85%
2018-06-30NZ$0.75 B-8.81%
2017-06-30NZ$0.83 B136.97%
2016-06-30NZ$0.35 B11.03%
2015-06-30NZ$0.31 B313.11%
2014-06-30NZ$76.6 M46.26%
2013-06-30NZ$52.37 M-6.35%
2012-06-30NZ$55.92 M46.46%
2011-06-30NZ$38.18 M53.76%
2010-06-30NZ$24.83 M3.32%
2009-06-30NZ$24.03 M-9.51%
2008-06-30NZ$26.56 M18.77%
2007-06-30NZ$22.36 M-54.77%
2006-06-30NZ$49.44 M25.8%
2005-06-30NZ$39.3 M-11.06%
2004-06-30NZ$44.19 M-3.48%
2003-06-30NZ$45.79 M-29.86%
2002-06-30NZ$65.28 M-29.9%
2001-06-30NZ$93.13 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$87.82 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.33 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.90 B 4,873.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.21 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.73 B 264.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$184.32 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.79 M-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA